查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575077

小动物影像（体内）市场规模、份额、趋势分析报告：按模式、按应用、按地区、细分市场预测，2024-2030 年

Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By Modality (Optical Imaging Systems, Micro-magnetic Resonance Imaging, Nuclear Imaging), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格
简介目录

小动物影像（体内）市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，2024年至2030年，全球小动物影像（体内）市场规模将以7.7%的复合年增长率扩张，预计到2030年将达到18.7亿美元。

预计越来越多的病理状况需要密切调查以开发治疗方法，这将推动预测期内小动物影像的需求。

这些设备在作用机制阐明、药物受体靶向和表观遗传学研究等应用中的重要性预计将推动市场的显着成长。小动物影像（体内）市场的主要驱动力是技术创新，例如使用其他模式的高解析度 MRI、研究和製药机构数量的增加、CRO 对临床前研究的投资增加以及多功能性。临床前成像。

小动物影像（体内）市场报告亮点

  • 与其他设备相比，光学成像由于操作快速简便且相对具有成本效益，将在 2023 年成为最大的细分市场。
  • 由于 MicroMRI 技术在发育中的小鼠胚胎和新生儿的解剖和功能分析中的多种应用，预计 MicroMRI 技术将成为预测期内成长最快的领域。
  • 2023年，生物分布和治疗反应监测在收益方面占据市场主导地位。
  • 由于癌症盛行率的增加以及政府对癌症诊断研究的倡议不断增加，癌细胞检测领域预计将显着增长。
  • 就 2023 年销售额而言，北美是最大的地区。大量的临床前研究、对快速和先进方法不断增长的需求、成熟的医疗基础设施、与技术进步相关的有利研发平台是推动该区域市场的关键因素。
  • 由于拥有大量的临床研究机构、製药公司和诊断设备製造商，欧洲将在2023年成为第二大地区。
  • 由于临床研究活动的增加、目标人口的成长和新兴经济体的成长，亚太地区预计将成为预测期内成长最快的地区。
  • 主要企业包括 Promega Corporation, Inc.、Miltenyi Biotec GmbH、PerkinElmer, Inc.、FujiFilm Holding Corporation、Siemens AG、Thermo Fisher Scientific、Bruker Corporation、PerkinElmer Inc. 和 Aspect Imaging Ltd。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章小动物影像（体内）市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 小动物影像（体内）市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 小动物影像（体内）市场：模态估计与趋势分析

  • 细分仪表板
  • 小动物影像（体内）市场：模态波动分析，2023/2030
  • 光学成像系统
  • 显微磁振造影
  • 核子造影
  • 其他成像方式

第五章小动物影像（体内）市场：应用评估与趋势分析

  • 细分仪表板
  • 小动物影像（体内）市场：2023 年和 2030 年应用变化分析
  • 监测药物治疗反应
  • 生物分布研究
  • 癌细胞检测
  • 生物标誌物
    • 2018-2030 年生物标记收益估计与预测
  • 纵贯研究
  • 表观遗传学

第六章小动物影像（体内）市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的小动物成像（体内）市场占有率，百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Aspect Imaging Ltd
    • PerkinElmer, Inc.
    • FUJIFILM Holdings Corporation
    • Miltenyi Biotec
    • Thermo Fisher Scientific Inc
    • Bruker
    • Siemens AG
    • Promega Corporation
    • Mediso
简介目录
Product Code: 978-1-68038-645-5

Small Animal Imaging (In-vivo) Market Growth & Trends:

The global small animal imaging (in-vivo) market size is expected to reach USD 1.87 billion by 2030, expanding at a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period.

Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging.

Small Animal Imaging (In-vivo) Market Report Highlights:

  • Optical imaging was the largest segment in 2023 owing to rapid and easy operations and relatively cost-effective in comparison to other devices
  • Micro-MRI technology is anticipated to be the fastest growing segment over the forecast period due varied applications during anatomical and functional analysis in developing mouse embryos and neonates
  • In 2023, bio-distribution and monitoring the treatment response dominated the market in terms of revenue
  • The cancer cell detection segment is expected to show substantial growth due to the increasing prevalence of cancer and rising government initiatives for cancer diagnostics research
  • North America was the largest region in terms of revenue in 2023. Vast pre-clinical research, increasing demand for rapid and advanced methods, established healthcare infrastructure, and favorable platform for R&D pertaining to technological advancements are the key factors driving the regional market
  • Europe was the second largest region in 2023, due to a large number of clinical research and pharmaceutical organizations and diagnostic device manufacturers
  • Asia Pacific is projected to be the fastest growing region over the forecast period owing to increasing clinical research activities, rising base of target population, and emerging economies
  • Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; PerkinElmer, Inc.; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Small Animal Imaging (In-vivo) Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Small Animal Imaging (In-vivo) Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Small Animal Imaging (In-vivo) Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Small Animal Imaging (In-vivo) Market: Modality Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Optical Imaging Systems
    • 4.3.1. Optical Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Bioluminescence Imaging
      • 4.3.2.1. Bioluminescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Cerenkov Luminescence Imaging
      • 4.3.3.1. Cerenkov Luminescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Fluorescence Imaging
      • 4.3.4.1. Fluorescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Micro-magnetic Resonance Imaging
    • 4.4.1. Micro-magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nuclear Imaging
    • 4.5.1. Nuclear Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Micro Positron Emission Tomography (Micro PET)
      • 4.5.2.1. Micro Positron Emission Tomography (Micro PET) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Micro Single Photon Emission Computerized Tomography (Micro SPECT)
      • 4.5.3.1. Micro Single Photon Emission Computerized Tomography (Micro SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Imaging Modalities
    • 4.6.1. Other Imaging Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Micro Computerized Tomography Imaging
      • 4.6.2.1. Micro Computerized Tomography Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Micro Ultrasound Imaging
      • 4.6.3.1. Micro Ultrasound Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Small Animal Imaging (In-vivo) Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Small Animal Imaging (In-vivo) Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Monitoring Drug Treatment Response
    • 5.3.1. Monitoring Drug Treatment Response Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biodistribution Studies
    • 5.4.1. Biodistribution Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cancer Cell Detection
    • 5.5.1. Cancer Cell Detection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Biomarkers
    • 5.6.1. Biomarkers Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Longitudinal Studies
    • 5.7.1. Longitudinal Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Epigenetics
    • 5.8.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Small Animal Imaging (In-vivo) Market: Regional Estimates & Trend Analysis

  • 6.1. Small Animal Imaging (In-vivo) Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Aspect Imaging Ltd
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. PerkinElmer, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. FUJIFILM Holdings Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Miltenyi Biotec
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Thermo Fisher Scientific Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Bruker
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Siemens AG
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Promega Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Mediso
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives